CARTRON; Guillaume

Patent Applications and Registrations

Patent applications and USPTO patent grants for CARTRON; Guillaume.The latest application filed is for "targeted human-interferon fusion proteins".

Company Profile

2.6.13

CARTRON; Guillaume - Combaillaux FR
Cartron; Guillaume - Montpellier FR
Cartron; Guillaume - Saint Christol FR
CARTRON; Guillaume - Montpellier Cedex 5 FR
Cartron; Guillaume - Savonnieres FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Targeted Human-interferon Fusion Proteins App 20210162010 - TAVERNIER; Jan ; et al.	2021-06-03
Targeted and mutated human-interferon fusion proteins Grant 10,946,070 - Tavernier , et al. March 16, 2	2021-03-16
Methods for predicting response to DNA repair pathway inhibitors in diffuse large B-cell lymphoma Grant 10,676,791 - Moreaux , et al.	2020-06-09
Targeted Human-interferon Fusion Proteins App 20180333465 - Tavernier; Jan ; et al.	2018-11-22
Lymphoid Hemopathy Prognosis Method App 20180246109 - Cartron; Guillaume ; et al.	2018-08-30
Targeted human-interferon fusion proteins Grant 10,034,919 - Tavernier , et al. July 31, 2	2018-07-31
Targeted Human-interferon Fusion Proteins App 20180028616 - Tavernier; Jan ; et al.	2018-02-01
Targeted human-interferon fusion proteins Grant 9,878,014 - Tavernier , et al. January 30, 2	2018-01-30
Methods For Predicting Response To Dna Repair Pathway Inhibitors In Diffuse Large B-cell Lymphoma App 20170211151 - MOREAUX; Jerome ; et al.	2017-07-27
Targeted Mutant Alpha-helical Bundle Cytokines App 20170072020 - Tavernier; Jan ; et al.	2017-03-16
Targeted human-interferon fusion proteins Grant 9,492,562 - Tavernier , et al. November 15, 2	2016-11-15
Methods And Compositions To Evaluate Antibody Treatment Response App 20150017633 - Watier; Herve ; et al.	2015-01-15
Targeted Mutant Alpha-helical Bundle Cytokines App 20140348789 - Tavernier; Jan ; et al.	2014-11-27
Method And Compositions For Cancer Prognosis App 20120027750 - Watier; Herve ; et al.	2012-02-02
Methods And Compositions To Evaluate Antibody Treatment Response App 20110123996 - Watier; Herve ; et al.	2011-05-26
Methods and compositions to evaluate antibody treatment response Grant 7,858,300 - Watier , et al. December 28, 2	2010-12-28
Fcgr3a Gebotype and Methods for Evaluating Treatment Response to Non-Depleting Antibodies App 20070231813 - Cartron; Guillaume ; et al.	2007-10-04
Methods and compositions to evaluate antibody treatment response App 20050064417 - Watier, Herve ; et al.	2005-03-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.